CD44 and melanoma: Hyaluronidases (HYAL1–4), the enzymes responsible for degrading HA, contribute to melanoma progression by generating low-molecular-weight HA fragments that enhance melanoma cell motility, invasion, and metastatic potential, and by modulating CD44- and RHAMM-mediated signalling pathways that support a pro-tumourigenic microenvironment [23].